GLP-1 drugs were identified using RxNav and RxClass from the National Library of Medicine, selecting all drugs within the Glucagon-like Peptide-1 (GLP-1) Agonists (N0000020058) Mechanism of Action class
Systemic Anti-Inflammatory Effects Patients with chronic inflammation, autoimmune conditions, or systemic pain syndromes have shown interest in the potential anti-inflammatory properties of both peptides Clinical Perspective: While patient motivations are valid, it is essential that expectations are calibrated to current evidence
Because of these regenerative effects, GHK-Cu is commonly used in anti-aging serums, cosmetic treatments, and emerging peptide therapies aimed at improving skin health and slowing visible aging
This process of course takes time, but if not protected, the water activity of the product will increase outside the ideal range and become soft
Several studies have explored this relationship, with varied results
Access this article Similar content being viewed by others Data availability The datasets used or analyzed in the current study are available from the corresponding author upon a reasonable request